Diabetes mellitus IIpacientes, tratamiento y adherencia terapéutica

  1. Chaxiraxi Morales Marrero 1
  2. Pablo del Rosario 1
  3. Susana Abdala Kuri 1
  4. Alexis Manuel Oliva Martín 1
  5. Sandra Dévora Gutiérrez 1
  1. 1 Universidad de La Laguna

    Universidad de La Laguna

    San Cristobal de La Laguna, España

    ROR https://ror.org/01r9z8p25

Majorensis: Revista Electrónica de Ciencia y Tecnología

ISSN: 1697-5529

Year of publication: 2021

Issue: 17

Pages: 42-50

Type: Article


Introduction: The proper knowledge of a given medication and the treatment compliance are two essential factors that should be present in order to obtain an optimum pharmacological treatment. Objectives: The main objectives of this study are to evaluate how pharmacist’s intervention can influence the knowledge and treatment compliance of diabetic type 2 patients and analyze the possible association that may exist between the two variables. Methodology: A prospective observational study, without a control group and consecutive sampling method was carried out at two community pharmacies. Both male and female 40 years and older diagnosed with type 2 diabetes mellitus and treated with A10B oral antidiabetic medication were considered as part of the study population. Result and discussion: At the initial visit, the 21 patients that were part of the study showed a good understanding of the following: medical indications, dosage, general guide lines, duration of the treatment, how to administer the medication, its effectiveness, and how to store the medication. On the other hand they showed a low level of knowledge regarding to drugs precautions, side effects, contraindications and interactions. The pharmacist’s intervention could produce a 57.1% increase in the percentage of knowledge that the patients had regarding their medication in contrast to the initial findings (p<0.0003, McNemar mid-p). The rate of treatment non-compliance showed a reduction of 23.8% in contrast to initial visit. The treatment non-compliance was mainly due to the patient forgetting to take the medication, the negative side effects arising, or the distrust of patients in their medication. Conclusion: The pharmaceutical intervention is able to improve the medication knowledge and treatment compliance of patience with type 2 diabetes. There has been found no association between the two variables.

Bibliographic References

  • American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2007; 30 Suppl 1: 4-41.
  • Andrés NF, Fornos JA, Andrés JC. Valoración del conocimiento/cumplimiento en un programa de seguimiento farmacoterapéutico en diabéticos tipo 2 en farmacia comunitaria: estudio aleatorizado. Pharm Care Esp 2007; 9(1): 2-9.
  • Baena MI, Fajardo P, Martínez J, Martínez F, et al. Cumplimiento, conocimiento y automedicación como factores asociados a los resultados clínicos negativos de la farmacoterapia. Ars Pharm 2005; 46(4): 365-81.
  • Boronat M, Varillas VF, Saavedra P, Suárez V, et al. Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain). Diabet Med 2006; 23: 148-155.
  • Bosworth HB, Oddone EZ, Weinberger M. Patient treatment adherence. Concepts, interventions and measurements. Lawrence Erlbaum Associates Publishers. London, 2006.
  • Cabrera A, Castillo JCD, Domínguez S, Rodríguez MDC, et al. Estilo de vida y adherencia al tratamiento de la población canaria con diabetes mellitus tipo 2. Rev Esp Salud Pública 2009; 83(4): 567-575.
  • Cabrera A, Rodríguez M, Almeida D, Domínguez S, et al. Presentación de la cohorte "CDC de Canarias": objetivos, diseño y resultados preliminares. Rev Esp Salud Pública 2008; 82(5): 519-534.
  • Cegala DJ, Marinelli T, Post D. The effects of patient communication skills training on compliance. Arch Fam Med 2000; 9: 57–64.
  • Consejo General de Colegios Oficiales. Bot Plus: Catálogo de Especialidades Farmacéuticas del Consejo General de Colegios Oficiales de Farmacéuticos. Madrid, 2012.
  • De Pablos PL, Martínez FJ, Rodríguez F, Anía BJ, Losada A, et al. Prevalence and determinants of diabetes mellitus and glucose intolerance in a Canarian Caucasian population: comparison of the 1997 ADA and the 1985 WHO criteria. Guide Study. Diabet Med 2001; 18: 235-241.
  • De Vries TPGM, Henning RH, Hogerzeil HV, Fresle DA. Guide to good prescribing. World Health Organization action program on essential drugs. Geneva, 1994.
  • De Vries TPGM. Presenting clinical pharmacology and therapeutics: A problem based approach for choosing and prescribing drugs. Br J Clin Pharmacol 1993; 35: 581–6.
  • DiMatteo MR. Variations in patient’s adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004; 42: 200- 9.
  • Fagerland MW, Lydersen S, Laake P. The McNemar test for binary matched-pairs data: mid- p and asymptotic are better than exact conditional. BMC Med Res Methodol 2013; 13(1): 91.
  • Fornos, JA, García P, Fernández M, González Añón D, et al. Evaluación del conocimiento, el cumplimiento y la satisfacción del tratamiento en pacientes diabéticos en la oficina de farmacia. Av Diabetol 2008; 24(5): 399-406.
  • Fornos JA, Andrés NF, Andrés JC, Guerra M, et al. A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain. Pharm World Sci 2006; 28(2): 65-72.
  • Fornos JA, Andrés NF, Guerra MM. Diseño y validación de un cuestionario de conocimiento sobre diabetes en pacientes de farmacia comunitaria. Pharm Care Esp 2003; 5: 268-274.
  • Foro de Atención Farmacéutica. Documento de consenso. Panorama Actual Med 2014; 38 (375): 645-76.
  • García P. Conocimiento del paciente sobre sus medicamentos. Tesis Doctoral. Granada, 2008.
  • García P, Gastelurrutia MA, Baena MI, Fisac F, et al. Validación de un cuestionario para medir el conocimiento de los pacientes sobre sus medicamentos. Aten Primaria 2009; 41(12): 661- 668.
  • Hernández M, Sierra F, López E, Dáder MJ, Olmos J, et al. Cumplimiento, conocimiento y automedicación como factores asociados a los resultados clínicos negativos de la farmacoterapia. Ars Pharm 2005; 46(4): 365-381.
  • International Diabetes Federation. Diabetes Atlas, 6th edition. The Global Burden. Brussels: International Diabetes Federation, 2013.
  • Jansà M, Vidal M. Importancia del cumplimiento terapéutico en la diabetes mellitus. Av Diabetol 2009; 25: 55-61.
  • Jiménez J. El conocimiento de los pacientes sobre su medicación es importante para su uso correcto. Aten Prim 2009; 41(12): 668-669.
  • Juez P. Herramientas estadísticas para la investigación en Medicina y Economía de la Salud. Ed. Centro de Estudios Ramón Areces. Madrid, 2001.
  • Kirkman M, Rowan M, Levin R, Fonseca V, et al. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database. Diabetes Care 2015; 38(4): 604- 609.
  • Ley Orgánica 03/2018, de 5 de diciembre, de Protección de Datos Personal y garantía de derechos digitales. BOE 294 de 06/12/2018.
  • Ley Orgánica 29/2006, de 26 de Julio, de garantías y uso racional de los medicamentos y productos sanitarios. BOE 178 de 27/07/2006.
  • Mann D, Ponieman D, Leventhal H, Halm E. Predictors of adherence to diabetes medications: the role of disease and medication beliefs. J Behav Med 2009; 32: 278-284.
  • Márquez E, Casado J, Márquez J. Estrategias para mejorar el cumplimiento terapéutico. FMC 2001; 8: 558–573.
  • Martínez, C. Una herramienta más para mejorar el cumplimiento terapéutico. Aten Prim 2009; 41(4): 191.
  • McNemar Q. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 1947, 12: 153–157
  • Menéndez A. Prevención de la diabetes tipo 2 basada en la terapia nutricional y/o el aumento de la actividad física. Av Diabetol 2009; 25: 110- 116.
  • Morisky D, Green L, Levine D. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24(1):67- 74.
  • Nathan D, Buse J, Davidson M, Heine R, et al. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care 2006; 29: 1963- 72.
  • Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, et al. Interventions for enhancing medication adherence. Cochrane Database Sys Rev2014, Issue 11. Art. No.: CD000011.
  • Nogués X et al. Instrumentos de medida de adherencia al tratamiento. An Med Interna 2007; 24(3): 138-41.
  • Pace A, Ochoa-Vigo K, Larcher M, Morais A. El conocimiento sobre diabetes mellitus en el proceso de autocuidado. Rev Latino-Am Enfermagen 2006; 14(5):10.
  • Peyrot M, Rubin R, Lauritzen T, Snoek F, et al. Psychological problems and barriers to improved diabetes management. Results of the Cross National Diabetes, Attitudes Whishes and Needs Whishes and Needs (DAWN) Study. Diabet Med 2005; 22: 1379-85.
  • R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, 2011
  • Ruiz M, Escolar A, Mayoral E, Corral F, et al. . La diabetes mellitus en España: mortalidad, prevalencia, incidencia, costes económicos y desigualdades. Gac Sanit 2006; 20: 15-24.
  • Soriguer F, Goday A, Bosch A, Bordiú E, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia 2012; 55: 88-93.
  • Valdés S, Rojo Martínez G, Soriguer F. Evolución de la prevalencia de la diabetes tipo 2 en población adulta española. Med Clin 2007; 129: 352-5.
  • Withley H, Fermo J, Ragucci K, Chumney EC. Assessment of patient knowledge of diabetic goals, self-reported medication adherence and goal attainment. Pharm Pract 2006; 4(4): 183- 190.
  • World Health Organization. Adherence to Longterm Therapies. Geneva, 2003.
  • World Health Organization. Índice de clasificación Anatómica, Terapéutica y Química (ATC) con Dosis Diarias Definidas. Collaborating Centre for Drug Statistics Methodology. Oslo, 1999.
  • World Health Organization. Declaración de Helsinki: recomendaciones para guiar a los médicos en la investigación biomédica en seres humanos. Helsinki, 2000.
  • World Health Organization. Teacher’s Guide to Good Prescribing, 2nd ed. Geneva, 2001